SUSAN TAYLOR: Open Payments
NPI 1023797594 · JOHNS ISLAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,237 in 106 payments from 21 companies in 2025. Trend: 2023 $152 · 2024 $2,129 · 2025 $2,237
Food & beverage: $2,237
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $405 |
| Vanda Pharmaceuticals Inc. | 20 | $392 |
| Neurocrine BioSciences, Inc. | 10 | $225 |
| ABBVIE INC. | 11 | $174 |
| Teva Pharmaceuticals USA, Inc. | 7 | $141 |
| Axsome Therapeutics, Inc. | 6 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Alkermes, Inc. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
Products named: COBENFY, HETLIOZ, INGREZZA, VRAYLAR, Auvelity, AUSTEDO XR, TRINTELLIX, CAPLYTA.
Industry payments across SC — which companies pay providers there.
